
The US government has exercised the last part of its option for supplies of smallpox vaccine Jynneos by Bavarian Nordic, according to a Friday press release.
This option is worth USD 12m and is part a USD 202m contract for smallpox vaccines which was agreed on in April 2020.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app